Clinical Trials Browser

Completed × Zoledronic Acid × Clear all

NCT03664687 2026-02-09

REaCT-ZOL

Phase 4 Completed

Breast Neoplasms

NCT02517918 2025-06-08

METZOLIMOS

Phase 1 Completed

23 enrolled 15 charts

Osteosarcoma

NCT01671774 2024-11-14

PILOT

Phase 1 Completed

Gastrointestinal

CLDN18.2-positive Gastric Adenocarcinoma

NCT03336983 2024-08-01

BonEnza

Phase 2 Completed

Prostatic Neoplasms

NCT00733538 2024-04-12

IFM-01-04

Phase 4 Completed

Multiple Myeloma

NCT00295646 2024-03-15

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Phase 3 Completed

1,803 enrolled 20 charts

Breast Neoplasms

NCT00556374 2023-07-27

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Phase 3 Completed

3,420 enrolled 19 charts

Breast Neoplasms

NCT00885326 2023-04-10

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT02286830 2023-02-17

Magnolia

Phase 4 Completed

Multiple Myeloma, Osteolysis, Osteonecrosis

NCT00321464 2022-11-08

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Phase 3 Completed

2,049 enrolled 16 charts

Breast Neoplasms, Fractures, Bone

NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Phase 3 Completed

1,718 enrolled 22 charts

Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT00330759 2022-11-07

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Phase 3 Completed

1,779 enrolled 14 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Spinal Cord Compression

NCT00566618 2022-02-25

Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis

Phase 1/2 Completed

31 enrolled 8 charts

Breast Neoplasms

NCT01951586 2021-10-25

Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer

Phase 2 Completed

226 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung

NCT00127205 2021-07-02

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

Phase 3 Completed

6,097 enrolled 20 charts

Breast Neoplasms

NCT00622505 2021-05-26

Z-MARK

Phase 4 Completed

121 enrolled 15 charts

Multiple Myeloma

NCT00424983 2020-12-21

Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year

Phase 1 Completed

BreastPlasma cell

Breast Neoplasms, Multiple Myeloma

NCT00079001 2020-05-12

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Phase 3 Completed

645 enrolled 13 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT00295867 2020-05-12

Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 2 Completed

45 enrolled 9 charts

Breast Neoplasms

NCT01087008 2020-04-06

AZABACHE

Phase 4 Completed

Multiple Myeloma

NCT00305695 2020-03-24

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

Phase 2 Completed

160 enrolled 10 charts

BreastGynecologic

Osteoporosis, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT01099436 2020-01-21

NEO-ZOTAC

Phase 3 Completed

Breast Neoplasms

NCT00213980 2019-11-27

Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer

Phase 2 Completed

68 enrolled 11 charts

Breast Neoplasms

NCT00582556 2019-11-26

Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy

Phase 2 Completed

44 enrolled 8 charts

Prostatic Neoplasms

NCT00987636 2019-10-22

EWING2008

Phase 3 Completed

Neoplasm Metastasis, Sarcoma, Ewing

NCT01006395 2019-07-05

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Phase 2/3 Completed

Insulin Resistance, Prostatic Neoplasms

NCT01367288 2019-05-28

NEOZOL

Phase 2 Completed

Breast Neoplasms, Neovascularization, Pathologic

NCT01205646 2019-04-12

PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer

Phase NA Completed

11 enrolled 7 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT00869206 2018-11-07

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

Phase 3 Completed

1,822 enrolled 19 charts

BreastGenitourinaryPlasma cell

Breast Neoplasms, Multiple Myeloma, Pain, Prostatic Neoplasms

NCT01194440 2018-09-12

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Phase 2 Completed

63 enrolled 7 charts

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00321620 2018-08-29

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate Cancer

Phase 3 Completed

1,904 enrolled 15 charts

Fractures, Bone

NCT00399802 2018-08-16

A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)

Phase 2 Completed

43 enrolled 10 charts

Bone Diseases, Breast Neoplasms

NCT00329797 2017-11-29

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Phase 3 Completed

109 enrolled 8 charts

Osteoporosis, Prostatic Neoplasms

NCT00193856 2017-10-12

RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

Phase 3 Completed

Prostatic Neoplasms

NCT00086268 2017-09-13

ZPACT

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01907880 2017-07-07

ER11-03

Phase 4 Completed

Breast Neoplasms, Pain

NCT00375648 2017-06-02

TRAPEZE

Phase 3 Completed

Neoplasms, Pain, Prostatic Neoplasms

NCT00171964 2017-06-01

Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions

Phase 4 Completed

Neoplasm Metastasis, Neoplasms, Pain

NCT00219271 2017-05-31

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

Phase 4 Completed

Prostatic Neoplasms

NCT01204203 2017-05-24

UAB0901

Phase 2 Completed

8 enrolled 5 charts

Other solid neoplasmThoracic

Mesothelioma

NCT01472146 2017-05-09

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

Phase 2 Completed

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

NCT02784652 2017-03-29

Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors

Phase 2 Completed

Gastrointestinal

Gastrointestinal Neoplasms

NCT00577642 2017-03-10

Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates

Phase 2 Completed

29 enrolled 8 charts

Multiple Myeloma

NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

Phase 2 Completed

61 enrolled 16 charts

GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

NCT00172055 2017-03-06

Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy

Phase 3 Completed

Osteoporosis, Prostatic Neoplasms

NCT00241111 2017-03-06

Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis

Phase 4 Completed

Neoplasms

NCT00171639 2017-02-23

The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis

Phase 3 Completed

Prostatic Neoplasms

NCT00237146 2017-02-23

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

Phase 4 Completed

Prostatic Neoplasms

NCT00242554 2017-02-23

Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases

Phase 4 Completed

Prostatic Neoplasms

NCT00434317 2017-02-23

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

Phase 4 Completed

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Pain, Prostatic Neoplasms